Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type.
Pratyusha VadagamDexter WatersInyoung LeeJustin ChenDajun TianAimee M NearDerek LyleJulie VanderpoelPublished in: Journal of medical economics (2024)
mutation types and were highest among exon20i cohort, potentially reflecting higher disease burden and unmet need among patients with this mutation.